0
13
Journal Articles about Antipsychotics Showing 61-80 of 931
Brief Report | October 01, 2006
Effect of 5-HT1A Receptor Gene Polymorphism on Negative and Depressive Symptom Response to Antipsychotic Treatment of Drug-Naive Psychotic Patients
Gavin P. Reynolds, Ph.D.; Belen Arranz, M.D., Ph.D.; Lucy A. Templeman, Ph.D.; Sofia Fertuzinhos, B.S.; Luis San, M.D., Ph.D.
The American Journal of Psychiatry. 2006 October ; 10(163):1826-1829
PDFPDF
Article | May 01, 2006
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
Thomas H. McGlashan, M.D.; Robert B. Zipursky, M.D.; Diana Perkins, M.D.; Jean Addington, Ph.D.; Tandy Miller, Ph.D.; Scott W. Woods, M.D.; Keith A. Hawkins, Psy.D.; Ralph E. Hoffman, M.D.; Adrian Preda, M.D.; Irvin Epstein, M.D., F.R.C.P.C.; Donald Addington, M.D.; Stacy Lindborg, Ph.D.; Quynh Trzaskoma, M.S.; Mauricio Tohen, M.D., Dr.P.H.; Alan Breier, M.D.
The American Journal of Psychiatry. 2006 May ; 5(163):790-799
PDFPDF
Article | May 01, 2006
Aripiprazole in the Treatment of Patients With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Study
Marius K. Nickel, M.D.; Moritz Muehlbacher, M.D.; Cerstin Nickel, M.D.; Christian Kettler, M.D.; Francisco Pedrosa Gil, M.D.; Egon Bachler, Ph.D.; Wiebke Buschmann, M.D.; Nadine Rother; Reinhold Fartacek, M.D.; Christoph Egger, M.D.; Javaid Anvar, M.D.; Wolfhardt K. Rother, M.D.; Thomas H. Loew, M.D.; Patrick Kaplan, M.D.
The American Journal of Psychiatry. 2006 May ; 5(163):833-838
PDFPDF
Article | April 01, 2006
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Joseph P. McEvoy, M.D.; Jeffrey A. Lieberman, M.D.; T. Scott Stroup, M.D., M.P.H.; Sonia M. Davis, Dr.P.H.; Herbert Y. Meltzer, M.D.; Robert A. Rosenheck, M.D.; Marvin S. Swartz, M.D.; Diana O. Perkins, M.D., M.P.H.; Richard S.E. Keefe, Ph.D.; Clarence E. Davis, Ph.D.; Joanne Severe, M.S.; John K. Hsiao, M.D.; for the CATIE Investigators
The American Journal of Psychiatry. 2006 April ; 4(163):600-610
PDFPDF  |    Data Supplements
Article | April 01, 2006
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
T. Scott Stroup, M.D., M.P.H.; Jeffrey A. Lieberman, M.D.; Joseph P. McEvoy, M.D.; Marvin S. Swartz, M.D.; Sonia M. Davis, Dr.P.H.; Robert A. Rosenheck, M.D.; Diana O. Perkins, M.D., M.P.H.; Richard S.E. Keefe, Ph.D.; Clarence E. Davis, Ph.D.; Joanne Severe, M.S.; John K. Hsiao, M.D.; for the CATIE Investigators
The American Journal of Psychiatry. 2006 April ; 4(163):611-622
PDFPDF  |    Data Supplements
Brief Report | April 01, 2006
Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia
Robin Emsley, M.D.; Jonathan Rabinowitz, Ph.D.; Rossella Medori, M.D.
The American Journal of Psychiatry. 2006 April ; 4(163):743-745
PDFPDF
Article | March 01, 2006
A PET Study Evaluating Dopamine D2 Receptor Occupancy for Long-Acting Injectable Risperidone
Gary Remington, M.D., Ph.D., FRCPC; David Mamo, M.D., M.Sc., FRCPC; Alain Labelle, M.D., FRCPC; Jeffrey Reiss, M.D., FRCPC; Chekkera Shammi, M.B.B.S., FRCPC; Erik Mannaert, Ph.D.; Steve Mann, B.A.; Shitij Kapur, M.D., Ph.D., FRCPC
The American Journal of Psychiatry. 2006 March ; 3(163):396-401
PDFPDF
Article | March 01, 2006
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders
Magali Reyes, M.D., Ph.D.; Jan Buitelaar, M.D.; Paz Toren, M.D.; Ilse Augustyns, Ph.D.; Marielle Eerdekens, M.D.
The American Journal of Psychiatry. 2006 March ; 3(163):402-410
PDFPDF
Article | March 01, 2006
Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers
Juan Francisco Artaloytia, M.D.; Celso Arango, M.D.; Adrienne Lahti, M.D.; Javier Sanz, M.D.; Ana Pascual, M.D.; Pedro Cubero, M.D.; David Prieto, M.Sc.; Tomás Palomo, M.D.
The American Journal of Psychiatry. 2006 March ; 3(163):488-493
PDFPDF
Article | March 01, 2006
Sildenafil in the Treatment of Antipsychotic-Induced Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose, Two-Way Crossover Trial
Rajesh Gopalakrishnan, M.D., D.P.M.; K.S. Jacob, M.D., Ph.D., M.R.C.Psych.; Anju Kuruvilla, M.D.; B. Vasantharaj, M.Sc.; Jacob K. John, M.D., F.R.C.Psych.
The American Journal of Psychiatry. 2006 March ; 3(163):494-499
PDFPDF
Brief Report | March 01, 2006
DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients
Todd Lencz, Ph.D.; Delbert G. Robinson, M.D.; Ke Xu,, M.D., Ph.D.; Jenny Ekholm, M.S.; Serge Sevy, M.D., M.B.A.; Handan Gunduz-Bruce, M.D.; Margaret G. Woerner, Ph.D.; John M. Kane, M.D.; David Goldman, M.D.; Anil K. Malhotra, M.D.
The American Journal of Psychiatry. 2006 March ; 3(163):529-531
PDFPDF
Reviews and Overviews | February 01, 2006
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
Stephan Heres, M.D.; John Davis, M.D.; Katja Maino, M.D.; Elisabeth Jetzinger, M.D.; Werner Kissling, M.D.; Stefan Leucht, M.D.
The American Journal of Psychiatry. 2006 February ; 2(163):185-194
PDFPDF
Article | February 01, 2006
Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine
Mauricio Tohen, M.D., Dr.P.H.; Joseph R. Calabrese, M.D.; Gary S. Sachs, M.D.; Michael D. Banov, M.D.; Holland C. Detke, Ph.D.; Richard Risser, M.S.; Robert W. Baker, M.D.; James C.-Y. Chou, M.D.; Charles L. Bowden, M.D.
The American Journal of Psychiatry. 2006 February ; 2(163):247-256
PDFPDF
Brief Report | January 01, 2006
Prevalence of the Night Eating Syndrome in a Psychiatric Population
Jennifer D. Lundgren, Ph.D.; Kelly C. Allison, Ph.D.; Scott Crow, M.D.; John P. O’Reardon, M.D.; Kelly C. Berg, B.S.; Juliette Galbraith, M.D.; Nicole S. Martino, B.S.; Albert J. Stunkard, M.D.
The American Journal of Psychiatry. 2006 January ; 1(163):156-158
PDFPDF
Article | December 01, 2005
Lateral and Medial Hypofrontality in First-Episode Schizophrenia: Functional Activity in a Medication-Naive State and Effects of Short-Term Atypical Antipsychotic Treatment
Beth E. Snitz, Ph.D.; Angus MacDonald, III, Ph.D.; Jonathan D. Cohen, M.D., Ph.D.; Raymond Y. Cho, M.D.; Theresa Becker, B.S.; Cameron S. Carter, M.D.
The American Journal of Psychiatry. 2005 December ; 12(162):2322-2329
PDFPDF
Article | October 01, 2005
Morphology of the Anterior Cingulate Gyrus in Patients With Schizophrenia: Relationship to Typical Neuroleptic Exposure
Alison Kopelman, M.D.; Nancy C. Andreasen, M.D., Ph.D.; Peg Nopoulos, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1872-1878
PDFPDF
Article | October 01, 2005
Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia
Alan Breier, M.D.; Paul H. Berg, M.S.; Jogin H. Thakore, M.D.; Dieter Naber, M.D.; Wagner F. Gattaz, M.D.; Patrizia Cavazzoni, M.D.; Daniel J. Walker, Ph.D.; Suraja M. Roychowdhury, Ph.D.; John M. Kane, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1879-1887
PDFPDF
Article | October 01, 2005
Treatment of Cognitive Impairment in Early Psychosis: A Comparison of Risperidone and Haloperidol in a Large Long-Term Trial
Philip D. Harvey, Ph.D.; Jonathan Rabinowitz, Ph.D.; Marielle Eerdekens, M.D.; Michael Davidson, M.D.
The American Journal of Psychiatry. 2005 October ; 10(162):1888-1895
PDFPDF
Brief Report | September 01, 2005
Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects Who Gained Weight With Olanzapine
Karen A. Graham, M.Sc., M.D.; Hongbin Gu, Ph.D.; Jeffrey A. Lieberman, M.D.; Joyce B. Harp, M.D.; Diana O. Perkins, M.D., M.P.H.
The American Journal of Psychiatry. 2005 September ; 9(162):1744-1746
PDFPDF
Brief Report | September 01, 2005
Effects of Antipsychotic Treatment on Emotion Perception Deficits in First-Episode Schizophrenia
Ellen S. Herbener, Ph.D.; S. Kristian Hill, Ph.D.; Robert W. Marvin, M.D.; John A. Sweeney, Ph.D.
The American Journal of Psychiatry. 2005 September ; 9(162):1746-1748
PDFPDF
Copyright ©
American
Psychiatric
Association